CDK4/6 Inhibitors in Melanoma: A Comprehensive Review

por Garutti, Mattia, Targato, Giada, Buriolla, Silvia, Palmero, Lorenza, Minisini, Alessandro Marco, Puglisi, Fabio
Publicado 2021

BRAF and MEK Inhibitors and Their Toxicities: A Meta-Analysis

por Garutti, Mattia, Bergnach, Melissa, Polesel, Jerry, Palmero, Lorenza, Pizzichetta, Maria Antonietta, Puglisi, Fabio
Publicado 2022

NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome

por Michelotti, Anna, de Scordilli, Marco, Palmero, Lorenza, Guardascione, Michela, Masala, Mario, Roncato, Rossana, Foltran, Luisa, Ongaro, Elena, Puglisi, Fabio
Publicado 2021

An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer

por Roncato, Rossana, Gerratana, Lorenzo, Palmero, Lorenza, Gagno, Sara, Poetto, Ariana Soledad, Peruzzi, Elena, Zanchetta, Martina, Posocco, Bianca, De Mattia, Elena, Canil, Giovanni, Alberti, Martina, Orleni, Marco, Toffoli, Giuseppe, Puglisi, Fabio, Cecchin, Erika
Publicado 2022

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study

por Basile, Debora, Gerratana, Lorenzo, Corvaja, Carla, Pelizzari, Giacomo, Franceschin, Giorgia, Bertoli, Elisa, Palmero, Lorenza, Zara, Diego, Alberti, Martina, Buriolla, Silvia, Da Ros, Lucia, Bonotto, Marta, Mansutti, Mauro, Spazzapan, Simon, Cinausero, Marika, Minisini, Alessandro Marco, Fasola, Gianpiero, Puglisi, Fabio
Publicado 2021

Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?

por Bortot, Lucia, Targato, Giada, Noto, Claudia, Giavarra, Marco, Palmero, Lorenza, Zara, Diego, Bertoli, Elisa, Dri, Arianna, Andreetta, Claudia, Pascoletti, Gaetano, Poletto, Elena, Russo, Stefania, Seriau, Luca, Mansutti, Mauro, Cedolini, Carla, Basile, Debora, Fasola, Gianpiero, Bonotto, Marta, Minisini, Alessandro Marco
Publicado 2022